Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RioMSK-001 by Rion for Osteoarthritis: Likelihood of Approval
RioMSK-001 is under clinical development by Rion and currently in Phase I for Osteoarthritis. According to GlobalData, Phase I drugs...